Search clinical trials for: Olanzapine, risperidone

Total 781 results

Janssen Pharmaceutica N.V., Belgium

Completed

RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice

Psychotic Disorders | Schizophrenia | Schizoaffective Disorder
McMaster University
College of Family Physicians of Canada; MediSystem Pharmacy

Unknown

Deprescribing Antipsychotics in Long-Term Care

Dementia | Behavior

Canada
University of Bergen

Completed

Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting (BPP)

Psychotic Disorders

Norway
University of Manchester
King's College London; Cardiff University; P1vital Limited

Completed

Effects of Ketamine and Risperidone on Cognition (Schiz_2)

Schizophrenia | Healthy Volunteers

United Kingdom
Teva Pharmaceuticals USA

Completed

A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Non-Fasting Conditions

Healthy

United States
Otsuka Pharmaceutical Development & Commercialization...
Otsuka America Pharmaceutical

Completed

Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.

Schizophrenia | Schizoaffective Disorder

United States
Rovi Pharmaceuticals Laboratories

Completed

Comparative Bioavailability of Risperidone.

Schizophrenia

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol

Bipolar Disorders | Manic Disorder
Kaohsiung Kai-Suan Psychiatric Hospital

Terminated

Comparison of the Efficacy and Safety of Risperidone Versus Risperidone Plus Low Dose of Haloperidol in the Treatment of Schizophrenia

Schizophrenia

Taiwan
AstraZeneca

Completed

Safety and Efficacy of Seroquel in First Episode Schizophrenia

Schizophrenia

United Kingdom
Inje University

Terminated

Quality of Life (QOL) in Female Patient With Schizophrenia

Schizophrenia

Korea, Republic of
Seattle Institute for Biomedical and Clinical Research
Janssen, LP

Completed

A Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence

Methamphetamine Dependence

United States
University of North Carolina, Chapel Hill
Eli Lilly and Company

Completed

Study of Amantadine for Weight Stabilization During Olanzapine Treatment

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Psychotic Disorder | Mood Disorders With Psychotic Features

United States
Dartmouth-Hitchcock Medical Center
National Institute of Mental Health (NIMH)

Completed

First Episode Schizophrenia and Cannabis-Related Disorder Study

Substance-Related Disorders | Psychotic Disorders | Schizophrenia | Cannabis-Related Disorder

United States
Merck Sharp & Dohme LLC

Completed

An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)

Schizophrenia, Acute Episode

United States
AstraZeneca

Completed

A Comparison of Seroquel vs. Risperidone in Schizophrenia

Schizophrenia

United States
Northwell Health
National Alliance for Research on Schizophrenia and Depression; The Zucker...

Terminated

Optimizing Response in Psychosis Study (ORP)

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Psychotic Disorder Not Otherwise Specified

United States
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Risperidone Tablet 1 mg Under Fasting Condition

Fasting

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Risperidone Tablet 1 mg Under Fed Condition

Fed

India
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States, India, Romania
Birte Glenthoj
Rigshospitalet, Denmark; University of Copenhagen; Hvidovre University Hospital; The Novo Nordic Foundation and other collaborators

Completed

Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia

Schizophrenia

Denmark
Janssen, LP

Completed

A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia

Psychotic Disorders | Schizophrenia
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia

Dementia | Alzheimer Disease | Dementia, Vascular
University of Connecticut
Janssen Pharmaceutica N.V., Belgium

Terminated

Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates

Aggression | Psychosis

United States
Eli Lilly and Company

Completed

An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients.

Schizophrenia | Bipolar Disorder

Germany, Greece, France
Eli Lilly and Company

Completed

Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With Schizophrenia

Schizophrenia

Japan
University of British Columbia
Bristol-Myers Squibb

Completed

Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI (CALM)

Psychotic Disorders | Bipolar Disorder | Metabolic Syndrome X

Canada
Janssen-Cilag International NV

Completed

InORS - International Observational Registry on Schizophrenia With Injectable Risperidone and Oral Antipsychotics

Schizophrenia

France, Germany, Spain, South Africa, Turkey, Greece, Czech Republic, Russian Federation
Janssen Scientific Affairs, LLC

Completed

A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform (DREaM)

Psychotic Disorders | Schizophrenia

United States, Brazil, Mexico
Mitsubishi Tanabe Pharma Corporation

Completed

Long-Term Study of MP-214 in Patients With Schizophrenia

Schizophrenia

Taiwan, Korea, Republic of, Japan
Janssen-Ortho Inc., Canada

Terminated

A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their Medication

Schizophrenia

Canada, United Kingdom, Australia, Ireland
Janssen Scientific Affairs, LLC

Completed

Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations

Schizophrenia | Bipolar Disorder

United States
University of Minnesota
Eli Lilly and Company

Completed

PET Imaging and Olanzapine Treatment in Borderline Personality Disorder

Borderline Personality Disorder

United States
Drexel University
National Institute of Mental Health (NIMH)

Completed

Long-Term Olanzapine Treatment in Children With Autism

Autism

United States
Shalvata Mental Health Center

Unknown

A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorders

Israel
China Medical University, China

Completed

Efficacy of Olanzapine Monotherapy for Treatment Bipolar Ⅰ Depression

Bipolar Disorder | Depression, Bipolar

China
Northwell Health
Eli Lilly and Company

Completed

Olanzapine in the Treatment of Anorexia Nervosa

Anorexia Nervosa

United States
Eli Lilly and Company

Completed

A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme

Weight Gain

Italy
Boehringer Ingelheim

Completed

SITS-IVT in Patients >80 Years Study (SITS_ELDERLY)

Ischaemic Stroke

Sweden
Merck Sharp & Dohme LLC

Active, not recruiting

Efficacy and Safety of MK-8189 in Participants With an Acute Episode of Schizophrenia (MK-8189-008)

Schizophrenia

United States, Bulgaria, Croatia, Japan, Korea, Republic of, Latvia, Poland, Romania, Russian Federation, Serbia, Taiwan, Ukraine
H. Lundbeck A/S
Otsuka Pharmaceutical Co., Ltd.

Withdrawn

Comparison of the Effectiveness of Brexpiprazole With That of Risperidone (TAILWIND)

Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I Outpatients

Bipolar Disorder
Shanghai Mental Health Center

Completed

A Study to Evaluate the Efficacy and Safety of Seroquel in Chinese Han Patients With Schizophrenia

Schizophrenia

China
Xingchen Peng

Recruiting

Olanzapine and 5-HT3 With or Without Dexamethasone to Prevent CINV

Chemotherapy-induced Nausea and Vomiting

China
Neuropsychiatric Research Institute, Fargo, North...
Eli Lilly and Company; University of North Dakota

Completed

Effects of Modafinil on Olanzapine Weight Gain

Weight Gain

United States
Kunming Medical University
National Natural Science Foundation of China

Completed

5-HTR2A, DRD2,and COMT Genes Polymorphisms and Olanzapine Plasma Concentration in Treatment of Early-onset Schizophrenia

Early-onset Schizophrenia

China
Tadashi Hasegawa

Completed

Olanzapine Versus Lithium in the Treatment of Acute Depression in Patients With Bipolar II or Bipolar Not Otherwise Specified(OL Study)

Bipolar Disorder

Japan
Rush University Medical Center

Completed

Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan

Nausea | Vomiting

United States
Orexigen Therapeutics, Inc

Terminated

Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder

United States
Chang Gung Memorial Hospital

Unknown

Neuroendocrine and Metabolite Substrates in Schizophrenia

Schizophrenia

Taiwan

Search clinical trials for: Olanzapine, risperidone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations